ST. GALLEN, Switzerland & BEIJING--(BUSINESS WIRE)-- Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com ...
ST. GALLEN, SWITZERLAND, March 19, 2024 /PRNewswire/ -- CSL Vifor today announced that Health Canada has authorized Ferinject (ferric carboxymaltose) for the intravenous (IV) treatment of iron ...
Results of a subanalysis from the FAIR-HF (Ferinject(R) Assessment in patients with IRon deficiency and Chronic Heart Failure) study demonstrate that correcting iron deficiency with Ferinject(R) ...
Swiss iron infusion maker Vifor Pharma is hunting for drugs to bolster its kidney- and heart-disease portfolio, sees deal-free years as "failures" and has the financial muscle to stay independent, ...
Vifor Pharma today presented the full results from the AFFIRM-AHF study at the 2020 American Heart Association (AHA) Scientific Sessions virtual congress. Simultaneously, results were published in the ...
17 August 2011 London: Hikma Pharmaceuticals (LSE: HIK) (NASDAQ Dubai: HIK) ("Hikma"), the fast growing pharmaceutical company, today announces that its wholly-owned subsidiary Hikma Pharmaceuticals ...
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221127005020/en/ CSL Vifor and Fresenius Kabi today ...
Sign up to receive daily headline news from Ottawa Citizen, a division of Postmedia Network Inc. CSL Vifor and Fresenius Kabi today announced that China’s National ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results